Target intelligence / Profile preview

Immunoglobulin superfamily DCC subclass member 3 pseudogene (IGDCC3 pseudogene)

Target
IGDCC3 pseudogene
Molecular classification
Pseudogene, Non-coding RNA
01

Overview

The Immunoglobulin superfamily DCC subclass member 3 pseudogene (ENSG00000231827, also known as LOC343052) is a genomic element in humans annotated as a pseudogene, which means it closely resembles a protein-coding gene but harbors disabling mutations and does not produce a functional protein[1][3][4][7][9]. Pseudogenes may be transcribed at low levels and can generate non-coding RNAs that occasionally have regulatory effects, including modulation of gene expression or chromatin state[2][10]. As a pseudogene, this locus has no established role as a receptor, enzyme, or drug target, and its biological function (if any) is limited to possible RNA-mediated regulatory effects that are rare, tissue-specific, and not well characterized for this gene[2][4][5]. No disease associations, drug interactions, or clinical biomarkers are reported for this entity.

Other names
IGDCC3 pseudogeneLOC343052ENSG00000231827
02

Mechanism of action

None established for drugs (see "interacting_drugs")[1][5][9]. Some pseudogenes may modulate gene expression via regulatory RNAs, but there are no drugs targeting this mechanism here[2][10].

03

Biological functions

Possible involvement in RNA-mediated gene regulation (as some pseudogenes can produce regulatory non-coding RNAs[2][10])May act as competing endogenous RNA (ceRNA) or microRNA decoy, with speculative, context-dependent evidence[2][10]Some pseudogene-derived RNAs have roles in chromatin repression[2]
04

Disease associations

Other (very limited evidence, general to pseudogenes: possible influence on cancer via regulatory RNAs, but no direct association for IGDCC3 pseudogene specifically[10])

Beyond the preview

Go deeper on Immunoglobulin superfamily DCC subclass member 3 pseudogene (IGDCC3 pseudogene).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Immunoglobulin superfamily DCC subclass member 3 pseudogene (IGDCC3 pseudogene).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call